Delivery Order SPE2DB20D2104-SPE2DB25FMCZY

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB22D1052|SPE2DB25FU7WP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $10,704.62 firm-fixed-price contract is for the delivery of 4566250982 JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, valued at $35,980.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is the prime contractor, with no set-aside designation...
This federal contract award, with an ID of SPE2DB22D2006|SPE2DB24FW0XP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,854.38 firm fixed-price delivery order is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMBLJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,933.40 firm fixed-price delivery order contract is for the supply of JARDIANCE 10 MG TABLET 90S. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,076.07 and is for the delivery of JARDIANCE 10 MG TABLET 90S. This is a Firm Fixed Price Delivery Order contract that runs through November 6, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FA27Q, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $31,056.59 firm fixed-price delivery order is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,369.92 Firm Fixed Price Delivery Order contract is for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award SPE2DB22D3011|SPE2DB23FQ1AV, with a ceiling value of $11,417.97, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4560957310 - JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a performance period through May 17, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, with identification number SPE2DB20D2104|SPE2DB25FMBAD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,131.21 firm fixed-price delivery order is for the supply of 4566177902 - JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays...
This federal contract award, valued at $6,331.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 20, 2025. This award is not associated with a set-aside designation, indicating open competition....
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMCZY
    Delivery Order

This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMCZY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, with a ceiling value of $7,981.01, is a Firm Fixed Price Delivery Order to provide the government with JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of November 29, 2024.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside requirement, indicating open competition.

Generated 5/20/25, 2:14 PM